NF-κB negatively impacts the myogenic potential of muscle-derived stem cells.
about
Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intakeA Novel NF-κB Inhibitor, Edasalonexent (CAT-1004), in Development as a Disease-Modifying Treatment for Patients With Duchenne Muscular Dystrophy: Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics in Adult SubjectsRhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice.Inhibition of NF-κB improves the stress resistance and myogenic differentiation of MDSPCs isolated from naturally aged miceMyogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response.NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy.Inferring genome-wide functional modulatory network: a case study on NF-κB/RelA transcription factorMuscle inflammation susceptibility: a prognostic index of recovery potential after hip arthroplasty?The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy.Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice.Inflammatory related gene IKKα, IKKβ, IKKγ cooperates to determine liver cancer stem cells progression by altering telomere via heterochromatin protein 1-HOTAIR axis.Arsenic Promotes NF-Κb-Mediated Fibroblast Dysfunction and Matrix Remodeling to Impair Muscle Stem Cell Function.Common pathways regulate Type III TGFβ receptor-dependent cell invasion in epicardial and endocardial cells.Muscle development, regeneration and laminopathies: how lamins or lamina-associated proteins can contribute to muscle development, regeneration and disease.Notch Signaling Mediates Skeletal Muscle Atrophy in Cancer Cachexia Caused by Osteosarcoma.Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.Wasting mechanisms in muscular dystrophy.Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humansDistinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy.NF-κB inhibition reveals a novel role for HGF during skeletal muscle repair.Early Growth Response 3 (Egr3) Contributes a Maintenance of C2C12 Myoblast Proliferation.Evolving paradigms in clinical pharmacology and therapeutics for the treatment of Duchenne muscular dystrophy.TNF- α and IFN-s-dependent muscle decay is linked to NF-κB- and STAT-1α-stimulated Atrogin1 and MuRF1 genes in C2C12 myotubes.Low-dose benzo(a)pyrene and its epoxide metabolite inhibit myogenic differentiation in human skeletal muscle-derived progenitor cells.NF-KB activity functions in primary pericytes in a cell- and non-cell-autonomous manner to affect myotube formation.LPS promote the odontoblastic differentiation of human dental pulp stem cells via MAPK signaling pathway.Genetic ablation of P65 subunit of NF-κB in mdx mice to improve muscle physiological function.RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion.Obese subcutaneous adipose tissue impairs human myogenesis, particularly in old skeletal muscle, via resistin-mediated activation of NFκBNF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model
P2860
Q28083422-26BB7BB8-DD7B-4683-BCDC-299957E516AFQ33625958-0B6EFDF9-81AD-414B-A1AD-C5535F8BB3AAQ33713641-B4FEAF00-5864-45A1-9AB3-FD3AE9C1DA3EQ33825230-DFD528AD-F876-4E9A-A598-15B2CB8C2622Q34103354-62985305-B0EF-4493-8E51-5ACF5160548DQ35190356-319ADE25-9960-4038-84BF-1B9174988B09Q35376685-93CF23D8-6E58-46CF-BCB1-80EA94C9D0C9Q35436852-D11D5FA7-7DD6-4FA9-B270-F3E337AE8DEAQ35524598-9D45B512-63C8-46DA-866D-423FF650D759Q35693925-055AC9F6-B78E-4D2C-B117-D8EA1117A5D5Q36065765-C5E4405D-FA71-4DAB-9D43-ABB412BE5ED3Q36756954-BF5E951E-27C9-423C-9EC3-5A9473D824D9Q36786619-B7038354-FAED-4126-913A-7CC91629A9D8Q37002317-2DE29D11-89A3-43E1-83D6-DD5DDEA00382Q37030454-D6909D53-B8FA-4B2D-94F0-C9FF443145A2Q37042189-C9FBA43D-43F0-4C80-920B-A01A36A64A03Q37138490-06B9BF3F-1DD0-4926-BA8D-66609E6F1881Q37150772-ED837067-8ACE-4B0B-A71E-2D6260E776C9Q37593034-A2487F71-A28A-4635-893B-F3DFC6D460D7Q38444259-AB06101B-6B3A-4B31-8719-215A40C8EB18Q38749013-00F68D55-4159-4643-9BBC-F4B4ADDC8DCFQ38806441-892FF676-9B4C-43E0-8325-301948B7C8D3Q39031553-7180A1D7-049A-41A3-AB77-ED351BADEF36Q42707391-9745C895-C27F-4D30-B004-0F769A0AA6CFQ44065862-EA7C0BCF-3767-4773-AF9F-E3185A42CFDEQ45028842-6B52B428-5661-4D77-86FA-AC0816E5E730Q45863094-79567BDE-161E-4CE7-80C5-AB71D43BAB20Q50977301-FD25E959-1D43-46F5-85BF-2AC2BBE9DF1AQ58603271-9A1278AF-60E2-4954-A947-6F09A1E6B37CQ58707771-6FE2C752-E408-4EE6-9031-E623AE24ED47
P2860
NF-κB negatively impacts the myogenic potential of muscle-derived stem cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
NF-κB negatively impacts the myogenic potential of muscle-derived stem cells.
@en
NF-κB negatively impacts the myogenic potential of muscle-derived stem cells.
@nl
type
label
NF-κB negatively impacts the myogenic potential of muscle-derived stem cells.
@en
NF-κB negatively impacts the myogenic potential of muscle-derived stem cells.
@nl
prefLabel
NF-κB negatively impacts the myogenic potential of muscle-derived stem cells.
@en
NF-κB negatively impacts the myogenic potential of muscle-derived stem cells.
@nl
P2093
P2860
P356
P1433
P1476
NF-κB negatively impacts the myogenic potential of muscle-derived stem cells.
@en
P2093
Denis C Guttridge
Jeremy S Tilstra
Johnny Huard
Jonathan D Proto
Laura J Niedernhofer
Mitra Lavasani
Paul D Robbins
P2860
P304
P356
10.1038/MT.2011.261
P577
2011-12-13T00:00:00Z